These data demonstrated that E2F1-mediated increase in ICAM-1 levels plays a role in killing tumor cells, which may represent another mechanism of the involvement of E2F1 in tumor growth beyond its effects in cell proliferation. Here, E2F1 is linked to neoplasm.